P04-46. Broadly cross-neutralizing activity in plasma of HIV-1 and HIV-2 infected individuals
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
P04-46. Broadly cross-neutralizing activity in plasma of HIV-1 and HIV-2 infected individuals ; volume:6 ; number:3 ; day:22 ; month:10 ; year:2009 ; pages:1 ; date:10.2009
Retrovirology ; 6, Heft 3 (22.10.2009), 1, 10.2009
- Urheber
-
Fenyö, Eva Maria
- Beteiligte Personen und Organisationen
-
Holmgren, B.
da Silva, ZJ
Nielsen, J.
Aaby, P.
Jansson, M.
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-6-S3-P74
- URN
-
urn:nbn:de:1111-201608077950
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fenyö, Eva Maria
- Holmgren, B.
- da Silva, ZJ
- Nielsen, J.
- Aaby, P.
- Jansson, M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Broadly Neutralizing Antibodies for HIV Eradication
Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
Identification of individuals with broadly neutralizing serum activity against HIV-1
Characterization of V1V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals
Characterization of V1/V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals
The expanding array of HIV broadly neutralizing antibodies
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Broadly Neutralizing Antibodies for HIV Eradication
Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
Identification of individuals with broadly neutralizing serum activity against HIV-1
Characterization of V1V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals
Characterization of V1/V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals
The expanding array of HIV broadly neutralizing antibodies
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Broadly Neutralizing Antibodies for HIV Eradication
Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
Identification of individuals with broadly neutralizing serum activity against HIV-1
Characterization of V1V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals
Characterization of V1/V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals
The expanding array of HIV broadly neutralizing antibodies
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
HIV-1 cell-to-cell transmission and broadly neutralizing antibodies